NASDAQ · Biotechnology

Ardelyx Inc (ARDX)

$3.89 -0.26%

Add alert

27 Oversold Daily RSI (14) · 21 Aug 2026

Moving averages

SMA 200$6.00-35.17%

Company profile

Ardelyx, Inc., a biopharmaceutical company, develops and sells drugs for the treatment of kidney and cardiorenal diseases in the United States and internationally. The company is headquartered in Fremont, California.

SectorHealthcare

IndustryBiotechnology

Market cap$1.03B

P/E ratioNone

EPS$-0.23

Beta0.731

Dividend yield0.00%

52-week high$8.40

52-week low$3.86

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 79 VRTX Vertex Pharmaceuticals Inc RSI 67 CRSP CRISPR Therapeutics AG RSI 67 IOVA Iovance Biotherapeutics Inc RSI 72 MRNA Moderna Inc RSI 72 VKTX Viking Therapeutics Inc RSI 48 SRPT Sarepta Therapeutics Inc RSI 59 EDIT Editas Medicine Inc RSI 57 NVAX Novavax Inc RSI 63 DNA Ginkgo Bioworks Holdings Inc - Class A RSI 46

Free forever

RSI alerts for ARDX

Get an email the moment Ardelyx Inc crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 14 August 2026 at 6:10 AM EDT